Wordt geladen...
Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae
Plazomicin is an aminoglycoside that was approved in June 2018 by the US Food and Drug Administration for the treatment of complicated urinary tract infections, including pyelonephritis, due to Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Proteus mirabilis. Plazomicin was engin...
Bewaard in:
| Gepubliceerd in: | Open Forum Infect Dis |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446133/ https://ncbi.nlm.nih.gov/pubmed/30968059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz123 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|